Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ibd CAncer and seRious Infections in France (I-CARE 2)

NCT06089590 is registered in ClinicalTrials.gov with Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives as lead sponsor.

NCT NCT06089590
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06089590 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ibd CAncer and seRious Infections in France (I-CARE 2)
Lead sponsor
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Phase
Observational
Overall status
Recruiting
Start date
January 25, 2024
Completion date
March 1, 2031
Enrollment
6,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, ibd, ulcerative colitis